Aspen Pharmacare is set to receive a R500m windfall following the resolution of a damaging legal battle with an undisclosed manufacturing client. This closes a seven-month chapter of significant financial uncertainty for Africa’s largest pharmaceutical producer. In a statement, Aspen advised shareholders that the dispute had been settled. The counterparty is required to pay the R500m “before December 1 2025,…